| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Baylin SB | |
| Herman JG | |||
| Issa JP | |||
| P921 | main subject | DNA methylation | Q874745 |
| P304 | page(s) | S7-11 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | Leukemia | Q6534498 |
| P1476 | title | DNA methylation changes in hematologic malignancies: biologic and clinical implications | |
| P478 | volume | 11 Suppl 1 |
| Q45355262 | Aberrant EPHB4 gene methylation and childhood acute lymphoblastic leukemia |
| Q39512176 | Abnormal hypermethylation and clinicopathological significance of Axin gene in lung cancer |
| Q36445921 | Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia |
| Q39698069 | Capillary electrophoretic analysis of genomic DNA methylation levels |
| Q35291843 | Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment concepts |
| Q33678040 | Demethylating Agents in the Treatment of Cancer |
| Q37324449 | Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia |
| Q46110570 | Effective treatment of low-dose decitabine in myelodysplastic syndrome/myeloproliferative neoplasms |
| Q51109149 | Estrogen promotes megakaryocyte polyploidization via estrogen receptor beta-mediated transcription of GATA1. |
| Q36362531 | Evaluation of X-Chromosome Inactivation Patterns in Patients with Acute Myeloid Leukemia during Remission |
| Q28366573 | Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer |
| Q37073998 | HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors |
| Q47869431 | Hematopoietic Stem Cells: Normal Versus Malignant. |
| Q39472965 | Identification of GLIPR1 tumor suppressor as methylation-silenced gene in acute myeloid leukemia by microarray analysis |
| Q37627410 | Impact of aberrant DNA methylation patterns including CYP1B1 methylation in adolescents and young adults with acute lymphocytic leukemia |
| Q37642044 | Inhibition of DNA and Histone Methylation by 5-Aza-2'-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells |
| Q37313719 | Just say no to ATOH: how HIC1 methylation might predispose medulloblastoma to lineage addiction |
| Q51787570 | Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome. |
| Q35764532 | Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas. |
| Q36203084 | Model-based adaptive phase I trial design of post-transplant decitabine maintenance in myelodysplastic syndrome |
| Q37148924 | Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in oligodendroglial tumors. |
| Q35948096 | Palliative chemotherapy followed by methylation inhibitor in high-risk acute myeloid leukemia: An in vitro and clinical study |
| Q45072707 | Readers of DNA methylation, the MBD family as potential therapeutic targets. |
| Q36284970 | Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression |
| Q38251339 | Targeting FLT3 to treat leukemia |
| Q90723422 | The Bright and Dark Side of DNA Methylation: A Matter of Balance |
| Q35597591 | The MethDet: a technology for biomarker development |
| Q26865165 | The diagnostic value of DNA methylation in leukemia: a systematic review and meta-analysis |
| Q38132064 | The evolving landscape in the therapy of acute myeloid leukemia |
| Q37765469 | Therapy with azanucleosides for myelodysplastic syndromes |
| Q36934199 | Treatment of acute myeloid leukemia with 20-30% bone marrow blasts |
| Q49547682 | p15Ink4b Loss of Expression by Promoter Hypermethylation Adds to Leukemogenesis and Confers a Poor Prognosis in Acute Promyelocytic Leukemia Patients |
Search more.